

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | L-phenylalanine catabolic process (GO:0006559) | 5.80185165 |
| 2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.80185165 |
| 3 | regulation of ER to Golgi vesicle-mediated transport (GO:0060628) | 5.52467194 |
| 4 | L-phenylalanine metabolic process (GO:0006558) | 5.48219861 |
| 5 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.48219861 |
| 6 | alpha-linolenic acid metabolic process (GO:0036109) | 5.25635899 |
| 7 | aromatic amino acid family catabolic process (GO:0009074) | 5.19146481 |
| 8 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 4.92114868 |
| 9 | homocysteine metabolic process (GO:0050667) | 4.71965522 |
| 10 | lysine catabolic process (GO:0006554) | 4.69176327 |
| 11 | lysine metabolic process (GO:0006553) | 4.69176327 |
| 12 | cysteine metabolic process (GO:0006534) | 4.67127859 |
| 13 | serine family amino acid catabolic process (GO:0009071) | 4.66919250 |
| 14 | indole-containing compound catabolic process (GO:0042436) | 4.66539820 |
| 15 | indolalkylamine catabolic process (GO:0046218) | 4.66539820 |
| 16 | tryptophan catabolic process (GO:0006569) | 4.66539820 |
| 17 | kynurenine metabolic process (GO:0070189) | 4.63791603 |
| 18 | fatty acid transmembrane transport (GO:1902001) | 4.63726014 |
| 19 | urea metabolic process (GO:0019627) | 4.63514043 |
| 20 | urea cycle (GO:0000050) | 4.63514043 |
| 21 | bile acid biosynthetic process (GO:0006699) | 4.60880495 |
| 22 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.51954278 |
| 23 | glyoxylate metabolic process (GO:0046487) | 4.48600596 |
| 24 | complement activation, alternative pathway (GO:0006957) | 4.47369429 |
| 25 | carnitine shuttle (GO:0006853) | 4.43568384 |
| 26 | tryptophan metabolic process (GO:0006568) | 4.41419155 |
| 27 | amino-acid betaine metabolic process (GO:0006577) | 4.37078478 |
| 28 | regulation of sequestering of triglyceride (GO:0010889) | 4.35676642 |
| 29 | nitrogen cycle metabolic process (GO:0071941) | 4.26957278 |
| 30 | regulation of triglyceride catabolic process (GO:0010896) | 4.24279376 |
| 31 | sulfur amino acid catabolic process (GO:0000098) | 4.23021570 |
| 32 | acylglycerol homeostasis (GO:0055090) | 4.18186872 |
| 33 | triglyceride homeostasis (GO:0070328) | 4.18186872 |
| 34 | pyrimidine nucleobase catabolic process (GO:0006208) | 4.15771482 |
| 35 | acetyl-CoA metabolic process (GO:0006084) | 4.15764039 |
| 36 | dicarboxylic acid biosynthetic process (GO:0043650) | 4.13132274 |
| 37 | fatty acid beta-oxidation (GO:0006635) | 4.12749723 |
| 38 | short-chain fatty acid metabolic process (GO:0046459) | 4.07334060 |
| 39 | alpha-amino acid catabolic process (GO:1901606) | 4.05617012 |
| 40 | bile acid metabolic process (GO:0008206) | 4.04150418 |
| 41 | regulation of protein activation cascade (GO:2000257) | 4.03708604 |
| 42 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.99199485 |
| 43 | high-density lipoprotein particle remodeling (GO:0034375) | 3.93989232 |
| 44 | fatty acid oxidation (GO:0019395) | 3.91891367 |
| 45 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.90417437 |
| 46 | protein carboxylation (GO:0018214) | 3.90417437 |
| 47 | cellular ketone body metabolic process (GO:0046950) | 3.89738077 |
| 48 | 2-oxoglutarate metabolic process (GO:0006103) | 3.86742275 |
| 49 | lipid oxidation (GO:0034440) | 3.85637917 |
| 50 | glutamate metabolic process (GO:0006536) | 3.81348787 |
| 51 | cellular amino acid catabolic process (GO:0009063) | 3.80815052 |
| 52 | fatty acid catabolic process (GO:0009062) | 3.80613037 |
| 53 | valine metabolic process (GO:0006573) | 3.79824175 |
| 54 | negative regulation of fibrinolysis (GO:0051918) | 3.79455051 |
| 55 | regulation of fibrinolysis (GO:0051917) | 3.79379315 |
| 56 | regulation of complement activation (GO:0030449) | 3.79130822 |
| 57 | biotin metabolic process (GO:0006768) | 3.78850913 |
| 58 | adaptation of signaling pathway (GO:0023058) | 3.75651746 |
| 59 | plasma lipoprotein particle clearance (GO:0034381) | 3.74162449 |
| 60 | phospholipid homeostasis (GO:0055091) | 3.73506138 |
| 61 | fatty acid homeostasis (GO:0055089) | 3.73378992 |
| 62 | positive regulation of lipid catabolic process (GO:0050996) | 3.71188837 |
| 63 | aromatic amino acid family metabolic process (GO:0009072) | 3.70996887 |
| 64 | tyrosine metabolic process (GO:0006570) | 3.69331344 |
| 65 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.63953331 |
| 66 | branched-chain amino acid catabolic process (GO:0009083) | 3.63479964 |
| 67 | monocarboxylic acid catabolic process (GO:0072329) | 3.63361301 |
| 68 | aspartate family amino acid catabolic process (GO:0009068) | 3.62968057 |
| 69 | positive regulation of fatty acid oxidation (GO:0046321) | 3.59682056 |
| 70 | reverse cholesterol transport (GO:0043691) | 3.59627991 |
| 71 | negative regulation of mast cell activation (GO:0033004) | 3.58318141 |
| 72 | imidazole-containing compound metabolic process (GO:0052803) | 3.54701233 |
| 73 | carboxylic acid catabolic process (GO:0046395) | 3.52592246 |
| 74 | organic acid catabolic process (GO:0016054) | 3.52592246 |
| 75 | coenzyme catabolic process (GO:0009109) | 3.51343786 |
| 76 | protein-lipid complex remodeling (GO:0034368) | 3.51085099 |
| 77 | macromolecular complex remodeling (GO:0034367) | 3.51085099 |
| 78 | plasma lipoprotein particle remodeling (GO:0034369) | 3.51085099 |
| 79 | glycine metabolic process (GO:0006544) | 3.51014462 |
| 80 | negative regulation of lipase activity (GO:0060192) | 3.50245631 |
| 81 | carnitine transmembrane transport (GO:1902603) | 3.49018379 |
| 82 | carnitine metabolic process (GO:0009437) | 3.47791226 |
| 83 | ethanol oxidation (GO:0006069) | 3.45724923 |
| 84 | neuronal action potential propagation (GO:0019227) | 3.45497581 |
| 85 | neutral lipid catabolic process (GO:0046461) | 3.44648289 |
| 86 | acylglycerol catabolic process (GO:0046464) | 3.44648289 |
| 87 | carnitine transport (GO:0015879) | 3.41861819 |
| 88 | amino-acid betaine transport (GO:0015838) | 3.41861819 |
| 89 | serine family amino acid metabolic process (GO:0009069) | 3.41608373 |
| 90 | triglyceride catabolic process (GO:0019433) | 3.37632000 |
| 91 | branched-chain amino acid metabolic process (GO:0009081) | 3.36644043 |
| 92 | cellular modified amino acid catabolic process (GO:0042219) | 3.36286889 |
| 93 | regulation of bile acid biosynthetic process (GO:0070857) | 3.36042557 |
| 94 | drug catabolic process (GO:0042737) | 3.35367487 |
| 95 | low-density lipoprotein particle clearance (GO:0034383) | 3.34649725 |
| 96 | neuron cell-cell adhesion (GO:0007158) | 3.33662153 |
| 97 | ketone body metabolic process (GO:1902224) | 3.32853619 |
| 98 | indolalkylamine metabolic process (GO:0006586) | 3.28804401 |
| 99 | nucleobase catabolic process (GO:0046113) | 3.28426242 |
| 100 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.24936907 |
| 101 | negative regulation of cholesterol transport (GO:0032375) | 3.23976602 |
| 102 | negative regulation of sterol transport (GO:0032372) | 3.23976602 |
| 103 | phospholipid efflux (GO:0033700) | 3.23575039 |
| 104 | cellular glucuronidation (GO:0052695) | 3.16038278 |
| 105 | * linoleic acid metabolic process (GO:0043651) | 3.13970467 |
| 106 | bile acid and bile salt transport (GO:0015721) | 3.12998159 |
| 107 | protein targeting to Golgi (GO:0000042) | 3.10681712 |
| 108 | response to pheromone (GO:0019236) | 3.08938771 |
| 109 | regulation of synapse structural plasticity (GO:0051823) | 3.08521613 |
| 110 | amine catabolic process (GO:0009310) | 3.08332038 |
| 111 | negative regulation of neurotransmitter transport (GO:0051589) | 3.03804588 |
| 112 | interleukin-6-mediated signaling pathway (GO:0070102) | 3.03538103 |
| 113 | establishment of protein localization to Golgi (GO:0072600) | 3.00596884 |
| 114 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.96366509 |
| 115 | auditory behavior (GO:0031223) | 2.95906324 |
| 116 | vesicle transport along microtubule (GO:0047496) | 2.95257479 |
| 117 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.95016319 |
| 118 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.95016319 |
| 119 | protein K11-linked deubiquitination (GO:0035871) | 2.91393279 |
| 120 | presynaptic membrane assembly (GO:0097105) | 2.86837002 |
| 121 | neural tube formation (GO:0001841) | 2.85033920 |
| 122 | synaptic vesicle maturation (GO:0016188) | 2.83533995 |
| 123 | nerve growth factor signaling pathway (GO:0038180) | 2.81774071 |
| 124 | neutrophil mediated immunity (GO:0002446) | 2.80851873 |
| 125 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.79458156 |
| 126 | detection of calcium ion (GO:0005513) | 2.77435364 |
| 127 | regulation of fever generation (GO:0031620) | 2.76590607 |
| 128 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 2.75622311 |
| 129 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.73848966 |
| 130 | regulation of heat generation (GO:0031650) | 2.72227119 |
| 131 | organelle transport along microtubule (GO:0072384) | 2.70644059 |
| 132 | positive regulation of heat generation (GO:0031652) | 2.69943101 |
| 133 | regulation of axon regeneration (GO:0048679) | 2.68022395 |
| 134 | regulation of neuron projection regeneration (GO:0070570) | 2.68022395 |
| 135 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.67438223 |
| 136 | exploration behavior (GO:0035640) | 2.66382845 |
| 137 | regulation of glucokinase activity (GO:0033131) | 2.66101603 |
| 138 | regulation of hexokinase activity (GO:1903299) | 2.66101603 |
| 139 | protein localization to cilium (GO:0061512) | 2.61848745 |
| 140 | axonal fasciculation (GO:0007413) | 2.60861403 |
| 141 | proline transport (GO:0015824) | 2.59521942 |
| 142 | platelet dense granule organization (GO:0060155) | 2.59404099 |
| 143 | regulation of feeding behavior (GO:0060259) | 2.57863635 |
| 144 | gamma-aminobutyric acid transport (GO:0015812) | 2.57778003 |
| 145 | regulation of synaptic vesicle transport (GO:1902803) | 2.57748826 |
| 146 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.57425035 |
| 147 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.56743047 |
| 148 | vocalization behavior (GO:0071625) | 2.55583506 |
| 149 | mechanosensory behavior (GO:0007638) | 2.54736962 |
| 150 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.51793851 |
| 151 | presynaptic membrane organization (GO:0097090) | 2.51512396 |
| 152 | neurotransmitter-gated ion channel clustering (GO:0072578) | 2.51158316 |
| 153 | protein localization to synapse (GO:0035418) | 2.50904465 |
| 154 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.50600899 |
| 155 | establishment of mitochondrion localization (GO:0051654) | 2.49573256 |
| 156 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.47319794 |
| 157 | negative regulation of JUN kinase activity (GO:0043508) | 2.44146119 |
| 158 | cAMP-mediated signaling (GO:0019933) | 2.43158353 |
| 159 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.40030453 |
| 160 | negative regulation of dendrite development (GO:2000171) | 2.39478519 |
| 161 | positive regulation of vasculogenesis (GO:2001214) | 2.39112960 |
| 162 | protein localization to Golgi apparatus (GO:0034067) | 2.38918865 |
| 163 | postsynaptic membrane organization (GO:0001941) | 2.37521807 |
| 164 | glutamate receptor signaling pathway (GO:0007215) | 2.37437006 |
| 165 | protein targeting to vacuole (GO:0006623) | 2.36847325 |
| 166 | protein targeting to lysosome (GO:0006622) | 2.36847325 |
| 167 | establishment of protein localization to vacuole (GO:0072666) | 2.36847325 |
| 168 | regulation of transmission of nerve impulse (GO:0051969) | 2.36433762 |
| 169 | synapse assembly (GO:0007416) | 2.35266670 |
| 170 | negative regulation of NF-kappaB import into nucleus (GO:0042347) | 2.32732470 |
| 171 | response to auditory stimulus (GO:0010996) | 2.30297023 |
| 172 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.30114991 |
| 173 | alanine transport (GO:0032328) | 2.28890510 |
| 174 | glycosphingolipid biosynthetic process (GO:0006688) | 2.28777204 |
| 175 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.28771327 |
| 176 | activated T cell proliferation (GO:0050798) | 2.28567314 |
| 177 | positive regulation of mitochondrial fission (GO:0090141) | 2.27499749 |
| 178 | myeloid leukocyte mediated immunity (GO:0002444) | 2.27140531 |
| 179 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.26133329 |
| 180 | dendritic spine morphogenesis (GO:0060997) | 2.25749021 |
| 181 | positive regulation of amino acid transport (GO:0051957) | 2.25617230 |
| 182 | neuron-neuron synaptic transmission (GO:0007270) | 2.25271208 |
| 183 | locomotory exploration behavior (GO:0035641) | 2.24690632 |
| 184 | regulation of action potential (GO:0098900) | 2.23670965 |
| 185 | piRNA metabolic process (GO:0034587) | 2.23581331 |
| 186 | regulation of cAMP-dependent protein kinase activity (GO:2000479) | 2.22917392 |
| 187 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.21572993 |
| 188 | dendrite morphogenesis (GO:0048813) | 2.21485812 |
| 189 | C4-dicarboxylate transport (GO:0015740) | 2.20846127 |
| 190 | dopamine biosynthetic process (GO:0042416) | 2.20375753 |
| 191 | regulation of neurotransmitter secretion (GO:0046928) | 2.19837198 |
| 192 | regulation of cilium movement (GO:0003352) | 2.19161185 |
| 193 | macroautophagy (GO:0016236) | 2.18645616 |
| 194 | neuron recognition (GO:0008038) | 2.18321521 |
| 195 | transmission of nerve impulse (GO:0019226) | 2.16697599 |
| 196 | glutamate secretion (GO:0014047) | 2.16312471 |
| 197 | cerebral cortex radially oriented cell migration (GO:0021799) | 2.15978402 |
| 198 | regulation of protein glycosylation (GO:0060049) | 2.15961806 |
| 199 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.14231358 |
| 200 | intraciliary transport (GO:0042073) | 2.13310564 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.26041890 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.21326648 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.77846517 |
| 4 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 4.58726349 |
| 5 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.38102441 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.33544910 |
| 7 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.13180204 |
| 8 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.37590201 |
| 9 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.11052938 |
| 10 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.02217382 |
| 11 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.89739500 |
| 12 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.44918723 |
| 13 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.42266296 |
| 14 | VDR_22108803_ChIP-Seq_LS180_Human | 2.34274023 |
| 15 | * TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.20326686 |
| 16 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 2.15683634 |
| 17 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 2.10757420 |
| 18 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.02992685 |
| 19 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.97349212 |
| 20 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.94900172 |
| 21 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.87192063 |
| 22 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.82260107 |
| 23 | * ER_23166858_ChIP-Seq_MCF-7_Human | 1.74597736 |
| 24 | * CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59287802 |
| 25 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.58987386 |
| 26 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.58947604 |
| 27 | FUS_26573619_Chip-Seq_HEK293_Human | 1.56862578 |
| 28 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.56810405 |
| 29 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.48580005 |
| 30 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.46525570 |
| 31 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.46471479 |
| 32 | EWS_26573619_Chip-Seq_HEK293_Human | 1.46296756 |
| 33 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.45619230 |
| 34 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.44826640 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.44624302 |
| 36 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.42734284 |
| 37 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.39215400 |
| 38 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38458014 |
| 39 | GATA1_22025678_ChIP-Seq_K562_Human | 1.36402156 |
| 40 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.35566829 |
| 41 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.35566829 |
| 42 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.33880596 |
| 43 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.33804154 |
| 44 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.31766151 |
| 45 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30501955 |
| 46 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.29875144 |
| 47 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.28043866 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.27695712 |
| 49 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.25252265 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.24651667 |
| 51 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.24223190 |
| 52 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.23311783 |
| 53 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.21964698 |
| 54 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21378111 |
| 55 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.21085334 |
| 56 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.21085334 |
| 57 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.20560320 |
| 58 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.17346123 |
| 59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.16435421 |
| 60 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.16318628 |
| 61 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.15587769 |
| 62 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.15586200 |
| 63 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.15423058 |
| 64 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 1.15314480 |
| 65 | TAL1_21186366_ChIP-Seq_BM-HSCs_Mouse | 1.15291133 |
| 66 | JUN_21703547_ChIP-Seq_K562_Human | 1.14925006 |
| 67 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.14761946 |
| 68 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.12439028 |
| 69 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.11628865 |
| 70 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.11354152 |
| 71 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10963035 |
| 72 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.10525209 |
| 73 | CJUN_26792858_Chip-Seq_BT549_Human | 1.10266374 |
| 74 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.10088463 |
| 75 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.09924672 |
| 76 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.08973088 |
| 77 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08235936 |
| 78 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.07376492 |
| 79 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.07360478 |
| 80 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.07360478 |
| 81 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.06776467 |
| 82 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.06300511 |
| 83 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.05707104 |
| 84 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03903130 |
| 85 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.03230775 |
| 86 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03068876 |
| 87 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.02867406 |
| 88 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.02759005 |
| 89 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.00820298 |
| 90 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.00059506 |
| 91 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 0.99689972 |
| 92 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.99498513 |
| 93 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98970278 |
| 94 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.97703319 |
| 95 | STAT3_23295773_ChIP-Seq_U87_Human | 0.97621682 |
| 96 | DROSHA_22980978_ChIP-Seq_HELA_Human | 0.97259959 |
| 97 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.96384569 |
| 98 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 0.95747859 |
| 99 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 0.94150638 |
| 100 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.93411244 |
| 101 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93382373 |
| 102 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 0.92846096 |
| 103 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92712307 |
| 104 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92592358 |
| 105 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.91210649 |
| 106 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.90293898 |
| 107 | * UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.89673276 |
| 108 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.88897508 |
| 109 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.88510882 |
| 110 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.88376912 |
| 111 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.88376912 |
| 112 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.87077484 |
| 113 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.86733330 |
| 114 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.86223299 |
| 115 | * P300_19829295_ChIP-Seq_ESCs_Human | 0.86062517 |
| 116 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.85604265 |
| 117 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85206622 |
| 118 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.84288471 |
| 119 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.83877882 |
| 120 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.83256443 |
| 121 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.81835035 |
| 122 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.81343495 |
| 123 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.81184427 |
| 124 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.81015904 |
| 125 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.80765668 |
| 126 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.80393003 |
| 127 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.80262047 |
| 128 | * TCF4_22108803_ChIP-Seq_LS180_Human | 0.79842965 |
| 129 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 0.79819882 |
| 130 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.79106274 |
| 131 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.78991362 |
| 132 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 0.78984009 |
| 133 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.78896402 |
| 134 | CBP_21632823_ChIP-Seq_H3396_Human | 0.78805649 |
| 135 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.78681440 |
| 136 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.78670310 |
| 137 | TCF4_23295773_ChIP-Seq_U87_Human | 0.78087307 |
| 138 | TP53_16413492_ChIP-PET_HCT116_Human | 0.77824192 |
| 139 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.77659007 |
| 140 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 0.76765879 |
| 141 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.76139194 |
| 142 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 0.76055854 |
| 143 | REST_21632747_ChIP-Seq_MESCs_Mouse | 0.74768712 |
| 144 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.73616849 |
| 145 | TCF3_18692474_ChIP-Seq_MESCs_Mouse | 0.73560085 |
| 146 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.73526002 |
| 147 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 0.73076135 |
| 148 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 0.73011344 |
| 149 | AR_19668381_ChIP-Seq_PC3_Human | 0.72372651 |
| 150 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 0.72184326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002139_abnormal_hepatobiliary_system | 6.86196645 |
| 2 | MP0005360_urolithiasis | 6.11183795 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 5.32198072 |
| 4 | MP0005365_abnormal_bile_salt | 5.20678845 |
| 5 | MP0000569_abnormal_digit_pigmentation | 4.34939924 |
| 6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.76820260 |
| 7 | MP0010329_abnormal_lipoprotein_level | 3.47145880 |
| 8 | MP0003880_abnormal_central_pattern | 3.39576288 |
| 9 | MP0003806_abnormal_nucleotide_metabolis | 3.37797000 |
| 10 | MP0003252_abnormal_bile_duct | 3.36387703 |
| 11 | MP0003787_abnormal_imprinting | 3.29210186 |
| 12 | MP0005670_abnormal_white_adipose | 3.05664219 |
| 13 | MP0004130_abnormal_muscle_cell | 2.84248510 |
| 14 | MP0003195_calcinosis | 2.72994340 |
| 15 | MP0005332_abnormal_amino_acid | 2.57666276 |
| 16 | MP0002837_dystrophic_cardiac_calcinosis | 2.45370969 |
| 17 | MP0005083_abnormal_biliary_tract | 2.36680876 |
| 18 | MP0008877_abnormal_DNA_methylation | 2.31584449 |
| 19 | MP0005666_abnormal_adipose_tissue | 2.28640987 |
| 20 | MP0002138_abnormal_hepatobiliary_system | 2.28271739 |
| 21 | MP0009745_abnormal_behavioral_response | 2.23935890 |
| 22 | MP0002118_abnormal_lipid_homeostasis | 2.23576797 |
| 23 | MP0002102_abnormal_ear_morphology | 2.21503095 |
| 24 | MP0004019_abnormal_vitamin_homeostasis | 2.14984425 |
| 25 | MP0003724_increased_susceptibility_to | 2.11329250 |
| 26 | MP0005423_abnormal_somatic_nervous | 2.11064728 |
| 27 | MP0002272_abnormal_nervous_system | 2.10383200 |
| 28 | MP0009840_abnormal_foam_cell | 1.92915845 |
| 29 | MP0002064_seizures | 1.92239374 |
| 30 | MP0000609_abnormal_liver_physiology | 1.91246194 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.87682116 |
| 32 | MP0001666_abnormal_nutrient_absorption | 1.87650996 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.86132634 |
| 34 | MP0003635_abnormal_synaptic_transmissio | 1.85881231 |
| 35 | MP0003303_peritoneal_inflammation | 1.84889074 |
| 36 | MP0002735_abnormal_chemical_nociception | 1.82207037 |
| 37 | MP0002063_abnormal_learning/memory/cond | 1.81135557 |
| 38 | MP0001529_abnormal_vocalization | 1.68893711 |
| 39 | MP0003646_muscle_fatigue | 1.67365761 |
| 40 | MP0001968_abnormal_touch/_nociception | 1.62332923 |
| 41 | MP0002736_abnormal_nociception_after | 1.61447255 |
| 42 | MP0005451_abnormal_body_composition | 1.61088458 |
| 43 | MP0001984_abnormal_olfaction | 1.60771305 |
| 44 | MP0001661_extended_life_span | 1.60062725 |
| 45 | MP0005253_abnormal_eye_physiology | 1.59974882 |
| 46 | MP0002653_abnormal_ependyma_morphology | 1.59133124 |
| 47 | MP0003868_abnormal_feces_composition | 1.58832860 |
| 48 | MP0005551_abnormal_eye_electrophysiolog | 1.58197458 |
| 49 | MP0002971_abnormal_brown_adipose | 1.57716429 |
| 50 | MP0002572_abnormal_emotion/affect_behav | 1.57711828 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.57620702 |
| 52 | MP0002254_reproductive_system_inflammat | 1.53421305 |
| 53 | MP0004142_abnormal_muscle_tone | 1.53117571 |
| 54 | MP0002638_abnormal_pupillary_reflex | 1.52706480 |
| 55 | MP0002822_catalepsy | 1.52158729 |
| 56 | MP0002734_abnormal_mechanical_nocicepti | 1.51699496 |
| 57 | MP0000778_abnormal_nervous_system | 1.50447885 |
| 58 | MP0003705_abnormal_hypodermis_morpholog | 1.48817944 |
| 59 | MP0003656_abnormal_erythrocyte_physiolo | 1.47878482 |
| 60 | MP0001502_abnormal_circadian_rhythm | 1.46910206 |
| 61 | MP0005319_abnormal_enzyme/_coenzyme | 1.45617112 |
| 62 | MP0005386_behavior/neurological_phenoty | 1.43533971 |
| 63 | MP0004924_abnormal_behavior | 1.43533971 |
| 64 | MP0001905_abnormal_dopamine_level | 1.41673036 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.37750136 |
| 66 | MP0004147_increased_porphyrin_level | 1.37738516 |
| 67 | MP0005375_adipose_tissue_phenotype | 1.37181594 |
| 68 | * MP0005535_abnormal_body_temperature | 1.35577322 |
| 69 | MP0006276_abnormal_autonomic_nervous | 1.34917976 |
| 70 | MP0010234_abnormal_vibrissa_follicle | 1.34638502 |
| 71 | MP0003121_genomic_imprinting | 1.34599426 |
| 72 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.33669127 |
| 73 | MP0001970_abnormal_pain_threshold | 1.33643026 |
| 74 | MP0004885_abnormal_endolymph | 1.32841313 |
| 75 | MP0003890_abnormal_embryonic-extraembry | 1.32084063 |
| 76 | MP0002078_abnormal_glucose_homeostasis | 1.31732462 |
| 77 | MP0005647_abnormal_sex_gland | 1.30316024 |
| 78 | MP0003221_abnormal_cardiomyocyte_apopto | 1.29760413 |
| 79 | MP0001764_abnormal_homeostasis | 1.26479061 |
| 80 | MP0005334_abnormal_fat_pad | 1.25915754 |
| 81 | MP0002876_abnormal_thyroid_physiology | 1.23764397 |
| 82 | MP0004484_altered_response_of | 1.21563128 |
| 83 | MP0006082_CNS_inflammation | 1.14665125 |
| 84 | MP0009780_abnormal_chondrocyte_physiolo | 1.14570818 |
| 85 | MP0003828_pulmonary_edema | 1.11966511 |
| 86 | MP0004043_abnormal_pH_regulation | 1.11197947 |
| 87 | MP0003631_nervous_system_phenotype | 1.09785923 |
| 88 | MP0002557_abnormal_social/conspecific_i | 1.06705144 |
| 89 | MP0003045_fibrosis | 1.05927929 |
| 90 | MP0009643_abnormal_urine_homeostasis | 1.05814197 |
| 91 | MP0003122_maternal_imprinting | 1.05634018 |
| 92 | MP0000920_abnormal_myelination | 1.04676184 |
| 93 | MP0004811_abnormal_neuron_physiology | 1.04393730 |
| 94 | MP0005646_abnormal_pituitary_gland | 1.02216973 |
| 95 | MP0004742_abnormal_vestibular_system | 0.99260962 |
| 96 | MP0010386_abnormal_urinary_bladder | 0.98605942 |
| 97 | MP0003690_abnormal_glial_cell | 0.97298596 |
| 98 | MP0002229_neurodegeneration | 0.96103659 |
| 99 | MP0009697_abnormal_copulation | 0.95837425 |
| 100 | MP0005448_abnormal_energy_balance | 0.93123861 |
| 101 | MP0002733_abnormal_thermal_nociception | 0.92331064 |
| 102 | MP0000647_abnormal_sebaceous_gland | 0.91262110 |
| 103 | * MP0006036_abnormal_mitochondrial_physio | 0.90155817 |
| 104 | MP0002882_abnormal_neuron_morphology | 0.88928636 |
| 105 | MP0006054_spinal_hemorrhage | 0.88221318 |
| 106 | MP0001188_hyperpigmentation | 0.87838417 |
| 107 | * MP0005266_abnormal_metabolism | 0.87150647 |
| 108 | MP0001986_abnormal_taste_sensitivity | 0.85632902 |
| 109 | MP0000427_abnormal_hair_cycle | 0.84078099 |
| 110 | MP0003950_abnormal_plasma_membrane | 0.83894929 |
| 111 | MP0000604_amyloidosis | 0.82256541 |
| 112 | MP0004215_abnormal_myocardial_fiber | 0.82138909 |
| 113 | MP0002148_abnormal_hypersensitivity_rea | 0.81242166 |
| 114 | MP0002269_muscular_atrophy | 0.79528597 |
| 115 | MP0005167_abnormal_blood-brain_barrier | 0.78782137 |
| 116 | MP0002277_abnormal_respiratory_mucosa | 0.78781069 |
| 117 | MP0000955_abnormal_spinal_cord | 0.77863048 |
| 118 | MP0009785_altered_susceptibility_to | 0.77458900 |
| 119 | MP0000013_abnormal_adipose_tissue | 0.77278660 |
| 120 | MP0008995_early_reproductive_senescence | 0.77166601 |
| 121 | * MP0009763_increased_sensitivity_to | 0.75629045 |
| 122 | MP0002184_abnormal_innervation | 0.75494299 |
| 123 | MP0003186_abnormal_redox_activity | 0.74206705 |
| 124 | MP0003953_abnormal_hormone_level | 0.73472791 |
| 125 | MP0002066_abnormal_motor_capabilities/c | 0.71742221 |
| 126 | MP0000343_altered_response_to | 0.71725776 |
| 127 | MP0000598_abnormal_liver_morphology | 0.71371817 |
| 128 | MP0002928_abnormal_bile_duct | 0.71341816 |
| 129 | MP0009115_abnormal_fat_cell | 0.70814059 |
| 130 | * MP0005376_homeostasis/metabolism_phenot | 0.70166739 |
| 131 | MP0005620_abnormal_muscle_contractility | 0.69543320 |
| 132 | MP0000003_abnormal_adipose_tissue | 0.69309653 |
| 133 | MP0001756_abnormal_urination | 0.68972296 |
| 134 | MP0009764_decreased_sensitivity_to | 0.64639953 |
| 135 | MP0004036_abnormal_muscle_relaxation | 0.64589006 |
| 136 | MP0003634_abnormal_glial_cell | 0.64523239 |
| 137 | MP0005164_abnormal_response_to | 0.63867138 |
| 138 | MP0009642_abnormal_blood_homeostasis | 0.63535446 |
| 139 | MP0008775_abnormal_heart_ventricle | 0.61880751 |
| 140 | MP0002909_abnormal_adrenal_gland | 0.61773538 |
| 141 | MP0000230_abnormal_systemic_arterial | 0.61490075 |
| 142 | MP0009672_abnormal_birth_weight | 0.59210676 |
| 143 | MP0001881_abnormal_mammary_gland | 0.58291688 |
| 144 | MP0002970_abnormal_white_adipose | 0.57995855 |
| 145 | MP0006035_abnormal_mitochondrial_morpho | 0.55698513 |
| 146 | MP0005452_abnormal_adipose_tissue | 0.55111097 |
| 147 | MP0004270_analgesia | 0.54889122 |
| 148 | MP0002168_other_aberrant_phenotype | 0.54717993 |
| 149 | MP0003329_amyloid_beta_deposits | 0.54634600 |
| 150 | MP0000579_abnormal_nail_morphology | 0.54581548 |
| 151 | MP0000751_myopathy | 0.53517321 |
| 152 | MP0009765_abnormal_xenobiotic_induced | 0.53286293 |
| 153 | MP0003011_delayed_dark_adaptation | 0.52734808 |
| 154 | MP0001501_abnormal_sleep_pattern | 0.52647517 |
| 155 | MP0005395_other_phenotype | 0.52389893 |
| 156 | MP0005636_abnormal_mineral_homeostasis | 0.52039022 |
| 157 | MP0004859_abnormal_synaptic_plasticity | 0.51753358 |
| 158 | * MP0002332_abnormal_exercise_endurance | 0.51395677 |
| 159 | MP0008961_abnormal_basal_metabolism | 0.51122380 |
| 160 | MP0001486_abnormal_startle_reflex | 0.50700624 |
| 161 | MP0005248_abnormal_Harderian_gland | 0.50612551 |
| 162 | MP0008872_abnormal_physiological_respon | 0.50212553 |
| 163 | MP0009046_muscle_twitch | 0.50083863 |
| 164 | MP0006138_congestive_heart_failure | 0.50049355 |
| 165 | MP0002090_abnormal_vision | 0.48952314 |
| 166 | MP0003633_abnormal_nervous_system | 0.47895441 |
| 167 | MP0005187_abnormal_penis_morphology | 0.47861570 |
| 168 | MP0003959_abnormal_lean_body | 0.46311967 |
| 169 | MP0005330_cardiomyopathy | 0.46174417 |
| 170 | MP0008874_decreased_physiological_sensi | 0.45713777 |
| 171 | MP0001440_abnormal_grooming_behavior | 0.44786102 |
| 172 | MP0004087_abnormal_muscle_fiber | 0.44459458 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Intrahepatic cholestasis (HP:0001406) | 5.91620140 |
| 2 | Hyperglycinuria (HP:0003108) | 5.42610402 |
| 3 | Hyperglycinemia (HP:0002154) | 5.15733561 |
| 4 | Deep venous thrombosis (HP:0002625) | 5.10179352 |
| 5 | Xanthomatosis (HP:0000991) | 5.08163620 |
| 6 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.06077920 |
| 7 | Abnormality of serine family amino acid metabolism (HP:0010894) | 4.94192509 |
| 8 | Abnormality of glycine metabolism (HP:0010895) | 4.94192509 |
| 9 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.75733499 |
| 10 | Hyperlipoproteinemia (HP:0010980) | 4.73407405 |
| 11 | Hypoalphalipoproteinemia (HP:0003233) | 4.69613400 |
| 12 | Ketosis (HP:0001946) | 4.65339534 |
| 13 | Hypoglycemic coma (HP:0001325) | 4.47224189 |
| 14 | Epidermoid cyst (HP:0200040) | 4.45175255 |
| 15 | Hyperammonemia (HP:0001987) | 4.42881225 |
| 16 | Prolonged partial thromboplastin time (HP:0003645) | 4.39083040 |
| 17 | Complement deficiency (HP:0004431) | 4.31845982 |
| 18 | Hypolipoproteinemia (HP:0010981) | 4.18955096 |
| 19 | Ketoacidosis (HP:0001993) | 4.14264499 |
| 20 | Atonic seizures (HP:0010819) | 4.12386148 |
| 21 | Hypobetalipoproteinemia (HP:0003563) | 4.09643795 |
| 22 | Focal motor seizures (HP:0011153) | 4.09418597 |
| 23 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.95676279 |
| 24 | Febrile seizures (HP:0002373) | 3.93571423 |
| 25 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.78590751 |
| 26 | Focal seizures (HP:0007359) | 3.58418291 |
| 27 | Abnormality of fatty-acid metabolism (HP:0004359) | 3.48799389 |
| 28 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.34058027 |
| 29 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.33375453 |
| 30 | Abnormality of serum amino acid levels (HP:0003112) | 3.29358097 |
| 31 | Polyphagia (HP:0002591) | 3.27908888 |
| 32 | Limb dystonia (HP:0002451) | 3.18031073 |
| 33 | Pancreatic cysts (HP:0001737) | 3.17258021 |
| 34 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 3.12970605 |
| 35 | Dialeptic seizures (HP:0011146) | 3.11721165 |
| 36 | Amyotrophic lateral sclerosis (HP:0007354) | 3.11403663 |
| 37 | True hermaphroditism (HP:0010459) | 3.10651280 |
| 38 | Abnormality of methionine metabolism (HP:0010901) | 3.10124282 |
| 39 | Hyperglycemia (HP:0003074) | 3.01169967 |
| 40 | Pancreatic fibrosis (HP:0100732) | 2.99838581 |
| 41 | Joint hemorrhage (HP:0005261) | 2.97308911 |
| 42 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.93960865 |
| 43 | Absent speech (HP:0001344) | 2.89985426 |
| 44 | Drooling (HP:0002307) | 2.88842506 |
| 45 | Hypercholesterolemia (HP:0003124) | 2.88819895 |
| 46 | Abnormality of the common coagulation pathway (HP:0010990) | 2.87908007 |
| 47 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.87502564 |
| 48 | Dicarboxylic aciduria (HP:0003215) | 2.87502564 |
| 49 | Fat malabsorption (HP:0002630) | 2.86440825 |
| 50 | Abnormality of nucleobase metabolism (HP:0010932) | 2.86284316 |
| 51 | Abnormality of purine metabolism (HP:0004352) | 2.82446041 |
| 52 | Hypoglycemic seizures (HP:0002173) | 2.82153244 |
| 53 | Skin nodule (HP:0200036) | 2.81314016 |
| 54 | Hemiparesis (HP:0001269) | 2.78314863 |
| 55 | Action tremor (HP:0002345) | 2.76979812 |
| 56 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.76785958 |
| 57 | Hydroxyprolinuria (HP:0003080) | 2.76770795 |
| 58 | Abnormality of proline metabolism (HP:0010907) | 2.76770795 |
| 59 | Chronic hepatic failure (HP:0100626) | 2.72486054 |
| 60 | Abnormality of complement system (HP:0005339) | 2.72371916 |
| 61 | Conjugated hyperbilirubinemia (HP:0002908) | 2.69849345 |
| 62 | Gout (HP:0001997) | 2.69737458 |
| 63 | Excessive salivation (HP:0003781) | 2.69197341 |
| 64 | Gait imbalance (HP:0002141) | 2.68474443 |
| 65 | Medial flaring of the eyebrow (HP:0010747) | 2.67144947 |
| 66 | Absence seizures (HP:0002121) | 2.66473083 |
| 67 | Delayed CNS myelination (HP:0002188) | 2.62031262 |
| 68 | Mutism (HP:0002300) | 2.61815956 |
| 69 | Abnormality of the intrinsic pathway (HP:0010989) | 2.60472203 |
| 70 | Papillary thyroid carcinoma (HP:0002895) | 2.58764543 |
| 71 | Metabolic acidosis (HP:0001942) | 2.57441826 |
| 72 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.56717004 |
| 73 | Pheochromocytoma (HP:0002666) | 2.54537932 |
| 74 | Renal cortical cysts (HP:0000803) | 2.53548518 |
| 75 | Myoglobinuria (HP:0002913) | 2.51048926 |
| 76 | Myocardial infarction (HP:0001658) | 2.50341089 |
| 77 | Metaphyseal dysplasia (HP:0100255) | 2.45610485 |
| 78 | Spastic diplegia (HP:0001264) | 2.44880654 |
| 79 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.43662962 |
| 80 | Oligomenorrhea (HP:0000876) | 2.43530772 |
| 81 | Hypothermia (HP:0002045) | 2.42990731 |
| 82 | Hyperuricemia (HP:0002149) | 2.42894386 |
| 83 | Increased purine levels (HP:0004368) | 2.42894386 |
| 84 | Abnormality of midbrain morphology (HP:0002418) | 2.42379907 |
| 85 | Molar tooth sign on MRI (HP:0002419) | 2.42379907 |
| 86 | Broad-based gait (HP:0002136) | 2.41433426 |
| 87 | Short tibia (HP:0005736) | 2.41247138 |
| 88 | Ulnar claw (HP:0001178) | 2.39534367 |
| 89 | Congenital primary aphakia (HP:0007707) | 2.35300685 |
| 90 | Generalized tonic-clonic seizures (HP:0002069) | 2.33596578 |
| 91 | Lethargy (HP:0001254) | 2.33307313 |
| 92 | Generalized aminoaciduria (HP:0002909) | 2.29736281 |
| 93 | Esotropia (HP:0000565) | 2.28015835 |
| 94 | Hypochromic microcytic anemia (HP:0004840) | 2.27509984 |
| 95 | Tubulointerstitial fibrosis (HP:0005576) | 2.27175078 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.26040628 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.26040628 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.26040628 |
| 99 | Nephrogenic diabetes insipidus (HP:0009806) | 2.24741729 |
| 100 | Pendular nystagmus (HP:0012043) | 2.24390149 |
| 101 | Hepatocellular carcinoma (HP:0001402) | 2.24328373 |
| 102 | Peripheral hypomyelination (HP:0007182) | 2.23979063 |
| 103 | Status epilepticus (HP:0002133) | 2.22830605 |
| 104 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.20099393 |
| 105 | Abolished electroretinogram (ERG) (HP:0000550) | 2.19957999 |
| 106 | Cortical dysplasia (HP:0002539) | 2.19103810 |
| 107 | EEG with generalized epileptiform discharges (HP:0011198) | 2.19026161 |
| 108 | Cerebral edema (HP:0002181) | 2.18225480 |
| 109 | Epileptiform EEG discharges (HP:0011182) | 2.17297142 |
| 110 | Stomatitis (HP:0010280) | 2.17255408 |
| 111 | Nephronophthisis (HP:0000090) | 2.17251521 |
| 112 | Hypsarrhythmia (HP:0002521) | 2.16398405 |
| 113 | Sensorimotor neuropathy (HP:0007141) | 2.13331846 |
| 114 | Spontaneous abortion (HP:0005268) | 2.12933929 |
| 115 | Alveolar cell carcinoma (HP:0006519) | 2.12285346 |
| 116 | Abnormality of the renal cortex (HP:0011035) | 2.11585637 |
| 117 | Neuroendocrine neoplasm (HP:0100634) | 2.09702376 |
| 118 | Pachygyria (HP:0001302) | 2.09413124 |
| 119 | Proximal tubulopathy (HP:0000114) | 2.07225983 |
| 120 | Hypertriglyceridemia (HP:0002155) | 2.07005105 |
| 121 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 2.06475869 |
| 122 | Thyroid carcinoma (HP:0002890) | 2.06370283 |
| 123 | Progressive cerebellar ataxia (HP:0002073) | 2.06351583 |
| 124 | Pancreatitis (HP:0001733) | 2.06016598 |
| 125 | Cholelithiasis (HP:0001081) | 2.05934006 |
| 126 | Esophageal varix (HP:0002040) | 2.05439497 |
| 127 | Exercise-induced myalgia (HP:0003738) | 2.05351962 |
| 128 | Hyperbilirubinemia (HP:0002904) | 2.05119156 |
| 129 | Rhabdomyolysis (HP:0003201) | 2.04112652 |
| 130 | Abnormal gallbladder morphology (HP:0012437) | 2.03754914 |
| 131 | Gaze-evoked nystagmus (HP:0000640) | 2.02723810 |
| 132 | Widely spaced teeth (HP:0000687) | 2.01623400 |
| 133 | Global brain atrophy (HP:0002283) | 2.01029732 |
| 134 | Postural instability (HP:0002172) | 1.99848801 |
| 135 | Albinism (HP:0001022) | 1.99102093 |
| 136 | Irritability (HP:0000737) | 1.98679504 |
| 137 | Agitation (HP:0000713) | 1.98029266 |
| 138 | Steatorrhea (HP:0002570) | 1.97428255 |
| 139 | Confusion (HP:0001289) | 1.97319978 |
| 140 | Abnormal biliary tract physiology (HP:0012439) | 1.96867642 |
| 141 | Bile duct proliferation (HP:0001408) | 1.96867642 |
| 142 | Spastic tetraplegia (HP:0002510) | 1.96480845 |
| 143 | Specific learning disability (HP:0001328) | 1.95302569 |
| 144 | Optic neuritis (HP:0100653) | 1.93415934 |
| 145 | Retrobulbar optic neuritis (HP:0100654) | 1.93415934 |
| 146 | Abnormal eating behavior (HP:0100738) | 1.92387358 |
| 147 | Abnormality of macular pigmentation (HP:0008002) | 1.92317615 |
| 148 | Neonatal onset (HP:0003623) | 1.91598058 |
| 149 | Genital tract atresia (HP:0001827) | 1.91426334 |
| 150 | Hemiplegia (HP:0002301) | 1.90662054 |
| 151 | Epileptic encephalopathy (HP:0200134) | 1.90449411 |
| 152 | Dysdiadochokinesis (HP:0002075) | 1.88284569 |
| 153 | Vascular calcification (HP:0004934) | 1.87896731 |
| 154 | Polydipsia (HP:0001959) | 1.87425051 |
| 155 | Abnormal drinking behavior (HP:0030082) | 1.87425051 |
| 156 | Turricephaly (HP:0000262) | 1.86772870 |
| 157 | Hyporeflexia of lower limbs (HP:0002600) | 1.86671290 |
| 158 | Symptomatic seizures (HP:0011145) | 1.85892185 |
| 159 | Acanthosis nigricans (HP:0000956) | 1.85087448 |
| 160 | Fair hair (HP:0002286) | 1.84705381 |
| 161 | Vomiting (HP:0002013) | 1.83996820 |
| 162 | Inappropriate behavior (HP:0000719) | 1.83215110 |
| 163 | Nausea (HP:0002018) | 1.82995700 |
| 164 | Parakeratosis (HP:0001036) | 1.82380663 |
| 165 | Enlarged kidneys (HP:0000105) | 1.81392464 |
| 166 | Neurofibrillary tangles (HP:0002185) | 1.81250972 |
| 167 | Generalized myoclonic seizures (HP:0002123) | 1.81105108 |
| 168 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 1.80722793 |
| 169 | Hematochezia (HP:0002573) | 1.80177043 |
| 170 | Disinhibition (HP:0000734) | 1.80132079 |
| 171 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.79769386 |
| 172 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.79769386 |
| 173 | Tetraparesis (HP:0002273) | 1.79386212 |
| 174 | Hemorrhage of the eye (HP:0011885) | 1.79038910 |
| 175 | Abnormality of the renal medulla (HP:0100957) | 1.77722334 |
| 176 | Dyskinesia (HP:0100660) | 1.76992255 |
| 177 | Tubular atrophy (HP:0000092) | 1.76818966 |
| 178 | Abnormality of the lower motor neuron (HP:0002366) | 1.75246468 |
| 179 | Tubulointerstitial abnormality (HP:0001969) | 1.74787828 |
| 180 | Generalized hypopigmentation (HP:0007513) | 1.74202768 |
| 181 | Delayed gross motor development (HP:0002194) | 1.73681084 |
| 182 | Myokymia (HP:0002411) | 1.73526949 |
| 183 | Progressive inability to walk (HP:0002505) | 1.73039734 |
| 184 | Abnormality of salivation (HP:0100755) | 1.72879467 |
| 185 | Atrioventricular block (HP:0001678) | 1.72647674 |
| 186 | Absent/shortened dynein arms (HP:0200106) | 1.71689380 |
| 187 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.71689380 |
| 188 | Stroke (HP:0001297) | 1.71103817 |
| 189 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.70830276 |
| 190 | Insulin resistance (HP:0000855) | 1.70700698 |
| 191 | Upper motor neuron abnormality (HP:0002127) | 1.67794850 |
| 192 | Hyperventilation (HP:0002883) | 1.65501490 |
| 193 | Brushfield spots (HP:0001088) | 1.65104960 |
| 194 | Difficulty running (HP:0009046) | 1.64802962 |
| 195 | Cardiovascular calcification (HP:0011915) | 1.64738775 |
| 196 | Limb hypertonia (HP:0002509) | 1.63604912 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 4.30289724 |
| 2 | CASK | 3.61361122 |
| 3 | INSRR | 3.35657580 |
| 4 | PDK3 | 3.20722980 |
| 5 | PDK4 | 3.20722980 |
| 6 | CAMK1D | 2.58448329 |
| 7 | MAP4K2 | 2.41747377 |
| 8 | MAP3K12 | 2.36201096 |
| 9 | MAP3K9 | 2.35986614 |
| 10 | EPHA3 | 2.30219045 |
| 11 | LATS1 | 2.25987248 |
| 12 | PDK2 | 2.15819867 |
| 13 | SIK1 | 2.13909952 |
| 14 | FRK | 2.12926554 |
| 15 | ERBB4 | 2.10622332 |
| 16 | MAP3K13 | 2.09935686 |
| 17 | MAP2K4 | 1.91124718 |
| 18 | FLT3 | 1.81509214 |
| 19 | CAMK1G | 1.80073318 |
| 20 | EIF2AK3 | 1.79808951 |
| 21 | PLK2 | 1.79507799 |
| 22 | STK38L | 1.76481050 |
| 23 | RIPK1 | 1.76030054 |
| 24 | DAPK2 | 1.72913793 |
| 25 | BMPR1B | 1.71001221 |
| 26 | MAP3K4 | 1.67979437 |
| 27 | ERBB3 | 1.66251132 |
| 28 | WNK3 | 1.61283487 |
| 29 | EPHA2 | 1.58526137 |
| 30 | MAPK13 | 1.57284444 |
| 31 | NTRK3 | 1.54122157 |
| 32 | PRKAA2 | 1.53927403 |
| 33 | IRAK1 | 1.49264351 |
| 34 | EPHA4 | 1.46153766 |
| 35 | BMPR2 | 1.45493875 |
| 36 | FGFR4 | 1.45337218 |
| 37 | NEK1 | 1.45048319 |
| 38 | FGFR2 | 1.44380398 |
| 39 | PKN2 | 1.40054546 |
| 40 | PHKG2 | 1.34866343 |
| 41 | PHKG1 | 1.34866343 |
| 42 | AKT3 | 1.33280935 |
| 43 | KSR2 | 1.31961161 |
| 44 | CAMKK2 | 1.28182920 |
| 45 | MAP2K7 | 1.27742565 |
| 46 | MARK1 | 1.24850623 |
| 47 | TRIM28 | 1.23645674 |
| 48 | CSNK1G2 | 1.21667939 |
| 49 | PRKAA1 | 1.20983151 |
| 50 | LATS2 | 1.19730640 |
| 51 | MAP3K7 | 1.18909276 |
| 52 | SGK2 | 1.18057761 |
| 53 | BRD4 | 1.12821076 |
| 54 | MAP3K2 | 1.12723439 |
| 55 | PINK1 | 1.12111398 |
| 56 | OXSR1 | 1.11938609 |
| 57 | STK38 | 1.10984059 |
| 58 | MINK1 | 1.07287927 |
| 59 | PRKCE | 1.05769333 |
| 60 | OBSCN | 1.05392998 |
| 61 | PRKD3 | 1.04339923 |
| 62 | SGK3 | 1.03042351 |
| 63 | PIK3CG | 1.00516868 |
| 64 | STK39 | 0.99672919 |
| 65 | KSR1 | 0.96784454 |
| 66 | PAK6 | 0.95968529 |
| 67 | TTN | 0.95233987 |
| 68 | ZAK | 0.92321743 |
| 69 | DYRK3 | 0.91129564 |
| 70 | SIK3 | 0.90204783 |
| 71 | CDK9 | 0.90168860 |
| 72 | TEC | 0.90137649 |
| 73 | LMTK2 | 0.84794991 |
| 74 | GRK7 | 0.84462762 |
| 75 | CSNK1G3 | 0.84006208 |
| 76 | ADRBK2 | 0.83808830 |
| 77 | WNK4 | 0.83509926 |
| 78 | MET | 0.82750136 |
| 79 | SGK494 | 0.81443174 |
| 80 | SGK223 | 0.81443174 |
| 81 | PDPK1 | 0.80312571 |
| 82 | FES | 0.79296869 |
| 83 | MAP3K3 | 0.79069233 |
| 84 | RET | 0.77061114 |
| 85 | PRKCZ | 0.76851907 |
| 86 | TRIB3 | 0.75758363 |
| 87 | JAK2 | 0.75376851 |
| 88 | ACVR1B | 0.74256295 |
| 89 | MST1R | 0.72826992 |
| 90 | MAPK11 | 0.69880520 |
| 91 | CSNK1G1 | 0.68221706 |
| 92 | CSNK1A1L | 0.67732029 |
| 93 | NTRK2 | 0.67329834 |
| 94 | PDK1 | 0.67116036 |
| 95 | MAPKAPK3 | 0.66965076 |
| 96 | SGK1 | 0.66029533 |
| 97 | CDK5 | 0.65714762 |
| 98 | CDK19 | 0.65097711 |
| 99 | PDGFRA | 0.64766889 |
| 100 | PAK3 | 0.64177349 |
| 101 | FER | 0.63983797 |
| 102 | PTK6 | 0.62313827 |
| 103 | PKN1 | 0.62006808 |
| 104 | JAK1 | 0.61940490 |
| 105 | STK11 | 0.61331590 |
| 106 | MAPKAPK5 | 0.60529114 |
| 107 | NTRK1 | 0.60229391 |
| 108 | TAOK3 | 0.59222584 |
| 109 | DYRK2 | 0.59118147 |
| 110 | NEK6 | 0.58734174 |
| 111 | CAMK2A | 0.58645056 |
| 112 | PRKACG | 0.57638373 |
| 113 | DYRK1A | 0.57335955 |
| 114 | IRAK2 | 0.56376003 |
| 115 | TIE1 | 0.54681881 |
| 116 | UHMK1 | 0.52761875 |
| 117 | MAP2K1 | 0.52017442 |
| 118 | NUAK1 | 0.50919398 |
| 119 | TGFBR2 | 0.50650718 |
| 120 | TNIK | 0.49275677 |
| 121 | PIK3CA | 0.48896933 |
| 122 | PRKG1 | 0.48103464 |
| 123 | MTOR | 0.47740153 |
| 124 | RAF1 | 0.47631830 |
| 125 | MAP3K5 | 0.47029979 |
| 126 | MAPK12 | 0.46926117 |
| 127 | RPS6KA3 | 0.44291238 |
| 128 | MAP3K6 | 0.43283199 |
| 129 | EIF2AK2 | 0.41935671 |
| 130 | IKBKE | 0.41553701 |
| 131 | ARAF | 0.40000085 |
| 132 | IKBKB | 0.38809268 |
| 133 | PRKACB | 0.37469215 |
| 134 | ERBB2 | 0.36400815 |
| 135 | GRK1 | 0.36322376 |
| 136 | SIK2 | 0.36072592 |
| 137 | PRKD1 | 0.35593483 |
| 138 | BCR | 0.35287729 |
| 139 | FGFR1 | 0.35212793 |
| 140 | CSNK1D | 0.35023056 |
| 141 | EGFR | 0.34757660 |
| 142 | STK16 | 0.34463793 |
| 143 | STK24 | 0.34163825 |
| 144 | PTK2B | 0.34062721 |
| 145 | MAPK10 | 0.33579247 |
| 146 | IRAK3 | 0.32791280 |
| 147 | PRKACA | 0.32560946 |
| 148 | NLK | 0.32499155 |
| 149 | AKT2 | 0.32481607 |
| 150 | CDK6 | 0.32399145 |
| 151 | STK3 | 0.31759492 |
| 152 | ABL1 | 0.31526017 |
| 153 | RPS6KB1 | 0.31155180 |
| 154 | FGFR3 | 0.30844071 |
| 155 | PRKCG | 0.30385499 |
| 156 | GSK3A | 0.29920911 |
| 157 | ERN1 | 0.29873774 |
| 158 | CAMKK1 | 0.29101489 |
| 159 | CAMK4 | 0.28998010 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.88407527 |
| 2 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 3.56734289 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.17934793 |
| 4 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.92368776 |
| 5 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.90778642 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.87128593 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.70718291 |
| 8 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.57746417 |
| 9 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.54236598 |
| 10 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.51491035 |
| 11 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.45776380 |
| 12 | Protein export_Homo sapiens_hsa03060 | 2.43382194 |
| 13 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.35478088 |
| 14 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.28891471 |
| 15 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.26570790 |
| 16 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.07433612 |
| 17 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.04275564 |
| 18 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.03382462 |
| 19 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.97698298 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.93576279 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.93473507 |
| 22 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.92533919 |
| 23 | Peroxisome_Homo sapiens_hsa04146 | 1.91024926 |
| 24 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.88074113 |
| 25 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.83655810 |
| 26 | Legionellosis_Homo sapiens_hsa05134 | 1.75403285 |
| 27 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.74929682 |
| 28 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.66164784 |
| 29 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.62798423 |
| 30 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.60967737 |
| 31 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.58854767 |
| 32 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.57704767 |
| 33 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.52052535 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.51964621 |
| 35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.50266557 |
| 36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.46717204 |
| 37 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.44950024 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.44077672 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.43075705 |
| 40 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.42758812 |
| 41 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.40406400 |
| 42 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.40188085 |
| 43 | Carbon metabolism_Homo sapiens_hsa01200 | 1.40029816 |
| 44 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.37790788 |
| 45 | Cocaine addiction_Homo sapiens_hsa05030 | 1.35639069 |
| 46 | Circadian entrainment_Homo sapiens_hsa04713 | 1.34308489 |
| 47 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.33388847 |
| 48 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.33043550 |
| 49 | Histidine metabolism_Homo sapiens_hsa00340 | 1.31820365 |
| 50 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.31103547 |
| 51 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.30528443 |
| 52 | Retinol metabolism_Homo sapiens_hsa00830 | 1.26023667 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.24047468 |
| 54 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.23595200 |
| 55 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.23200462 |
| 56 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.22009395 |
| 57 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.21386177 |
| 58 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.19007268 |
| 59 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.18700325 |
| 60 | Phagosome_Homo sapiens_hsa04145 | 1.18613901 |
| 61 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.17006502 |
| 62 | ABC transporters_Homo sapiens_hsa02010 | 1.15244135 |
| 63 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.14122112 |
| 64 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.12791338 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.10770052 |
| 66 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.09276519 |
| 67 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.07697771 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.06466963 |
| 69 | Tuberculosis_Homo sapiens_hsa05152 | 1.02675722 |
| 70 | Pertussis_Homo sapiens_hsa05133 | 1.00495874 |
| 71 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.99880301 |
| 72 | Long-term depression_Homo sapiens_hsa04730 | 0.98201151 |
| 73 | Lysine degradation_Homo sapiens_hsa00310 | 0.97300146 |
| 74 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.96585452 |
| 75 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.96052844 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.94170536 |
| 77 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93759894 |
| 78 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.91484041 |
| 79 | Taste transduction_Homo sapiens_hsa04742 | 0.91393120 |
| 80 | Asthma_Homo sapiens_hsa05310 | 0.89941661 |
| 81 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.88606632 |
| 82 | Salmonella infection_Homo sapiens_hsa05132 | 0.88344776 |
| 83 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.86793348 |
| 84 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.86380033 |
| 85 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.86178421 |
| 86 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.84536515 |
| 87 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.84380855 |
| 88 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.84268739 |
| 89 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.84087799 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.82149346 |
| 91 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.82010058 |
| 92 | Malaria_Homo sapiens_hsa05144 | 0.81439626 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.75779135 |
| 94 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.75404055 |
| 95 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.73564992 |
| 96 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.72527286 |
| 97 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.72008140 |
| 98 | Salivary secretion_Homo sapiens_hsa04970 | 0.71875012 |
| 99 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.71446029 |
| 100 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71214874 |
| 101 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.70220546 |
| 102 | Lysosome_Homo sapiens_hsa04142 | 0.69894118 |
| 103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.69408545 |
| 104 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.69074479 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.68625068 |
| 106 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.67434661 |
| 107 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.67359437 |
| 108 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.66131085 |
| 109 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.65989533 |
| 110 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.65428579 |
| 111 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.64961644 |
| 112 | Mineral absorption_Homo sapiens_hsa04978 | 0.64022388 |
| 113 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.63374426 |
| 114 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.62705915 |
| 115 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.62551987 |
| 116 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.62365781 |
| 117 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59433329 |
| 118 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.58791264 |
| 119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.53572425 |
| 120 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.53457324 |
| 121 | Leishmaniasis_Homo sapiens_hsa05140 | 0.52901889 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.50951763 |
| 123 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.50756892 |
| 124 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.49609869 |
| 125 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.49431860 |
| 126 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.49010606 |
| 127 | Parkinsons disease_Homo sapiens_hsa05012 | 0.48887227 |
| 128 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.48742490 |
| 129 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.47298883 |
| 130 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.47086360 |
| 131 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.46801402 |
| 132 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.45452953 |
| 133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45185603 |
| 134 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.44990476 |
| 135 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.44599466 |
| 136 | Influenza A_Homo sapiens_hsa05164 | 0.44170141 |
| 137 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.43371561 |
| 138 | Alzheimers disease_Homo sapiens_hsa05010 | 0.42723797 |
| 139 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42232555 |
| 140 | Gap junction_Homo sapiens_hsa04540 | 0.41920514 |
| 141 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.41633692 |
| 142 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.41340062 |
| 143 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.39709407 |
| 144 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39052581 |
| 145 | Prion diseases_Homo sapiens_hsa05020 | 0.32702722 |
| 146 | Metabolic pathways_Homo sapiens_hsa01100 | 0.32278780 |
| 147 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.27860914 |
| 148 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.26673120 |
| 149 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.24630870 |
| 150 | Nicotine addiction_Homo sapiens_hsa05033 | 0.23112333 |
| 151 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.22985517 |
| 152 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.17736689 |
| 153 | GABAergic synapse_Homo sapiens_hsa04727 | 0.16133427 |
| 154 | Insulin secretion_Homo sapiens_hsa04911 | 0.15244725 |
| 155 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.14843431 |
| 156 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.14421125 |
| 157 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.13903122 |
| 158 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.13241254 |
| 159 | Sulfur relay system_Homo sapiens_hsa04122 | 0.12503111 |
| 160 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.12465701 |
| 161 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.10469679 |
| 162 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.09930386 |
| 163 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.09660843 |
| 164 | Circadian rhythm_Homo sapiens_hsa04710 | 0.08986933 |
| 165 | Galactose metabolism_Homo sapiens_hsa00052 | 0.07034599 |
| 166 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.05874063 |
| 167 | Renin secretion_Homo sapiens_hsa04924 | 0.05387579 |
| 168 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.04623411 |
| 169 | Morphine addiction_Homo sapiens_hsa05032 | 0.02533379 |
| 170 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.00877906 |
| 171 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.00485752 |
| 172 | Regulation of autophagy_Homo sapiens_hsa04140 | -0.0115143 |

